Compare T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
T-Rex 2X Inverse MSTR Daily Target ETF vs Tempus AI — how do they compare? T-Rex 2X Inverse MSTR Daily Target ETF trades at $2.74 (market cap $94.46M), while Tempus AI trades at $72.76 (market cap $12.58B). The key difference: Tempus AI is far larger — about 133.2× T-Rex 2X Inverse MSTR Daily Target ETF's market cap, and Tempus AI is trading nearer its 52-week high, T-Rex 2X Inverse MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold T-Rex 2X Inverse MSTR Daily Target ETF for 8 Days and Tempus AI for 22 Days on average.
| MSTZ | TEM | |
|---|---|---|
Market Cap | $94.46M | $12.58B |
Volume | 104,717,733 | 7,444,569 |
Sector | Leveraged / Inverse | Broad Market / Factor |
52-Week High | $27.92 | $99.28 |
52-Week Low | $2.29 | $41.55 |
Typical Hold Time | 8 Days | 22 Days |
Enterprise Value | — | $13.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MSTZ is trading at $2.66, up 13.43% today, but technical indicators signal a bearish trend with moving averages and overall momentum favoring sellers. Key financial ratios such as P/E, P/S, and P/B are unavailable, limiting fundamental clarity. The stock's recent mention in ETF Trends (September 15, 2026) highlights its inclusion in leveraged ETF discussions, though this reflects market volatility rather than company-specific news.
The outlook is cautious due to weak technicals and missing fundamental data. Risks include high volatility from leveraged ETF exposure and lack of transparent financials. Investors should seek updated SEC filings for earnings and valuation metrics before considering a position, as current data gaps hinder a reliable assessment of growth or stability.
Tempus AI (TEM) trades at $72.15, up 2.65% today, with a bullish technical signal and strong analyst support. The stock shows recent earnings beats but remains unprofitable, with a net income margin of -17.77% for 2026. Positive developments include FDA clearance for an AI product and expanded data partnerships, fueling investor optimism in the healthtech sector.
Outlook is cautiously optimistic given growth potential in AI-driven diagnostics, but high valuation (P/S 8.61) and persistent losses pose risks. Upside hinges on revenue scaling and path to profitability, with a consensus price target of $72.60 suggesting limited near-term gains from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
